Elevating Our Communities With Every Interaction

Velocity is the world's leading integrated site organization.

Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.

Simplify everything from site selection to study close-out

Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.

+
Research sites across the U.S. and Europe
+
Investigators with diverse experience
+
Clinical trials conducted since 1986
treatment
mother-and-child-2
Hallandale
caring african medical nurse comforting senior patient in office
Velocity-team-office

The right sites.
The right investigators.
The right partner for you.

Strategically located to give you access to diverse specialty populations, Velocity's sites are supported by next-gen technologies and patient engagement capabilities. Welcome to recruitment and retention reimagined.

Scale for a purpose: Supporting research programs worldwide

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health.

Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, contact Velocity.

News

Velocity’s VISION Reaches More than $12.6 Million in Payments and 10,000 Randomizations

June 11, 2025

VISION has now contributed to more than 10,000 participant randomizations worldwide. Additionally, over $12.6 million in stipends have been paid through the VISION Engage mobile app, which is active in … Read more

Henrik Watz, MD, PhD, Named Top COPD Scholar

May 27, 2025

Henrik Watz, MD, PhD, has been named a 2024 Top Scholar by ScholarGPS, ranked #34 globally among chronic obstructive pulmonary disease (COPD) researchers over the past five years, and recognized … Read more

Henrik Watz, MD, PhD, Presents Promising Asthma Trial Results at ATS 2025

May 22, 2025

Henrik Watz, MD, PhD, presented compelling real-world data at the American Thoracic Society Annual Meeting on the long-term impact of dupilumab therapy in patients with severe asthma. Participants in the … Read more

Beyond the U.S.: How Velocity is Redefining Clinical Trials Internationally

May 15, 2025

When Velocity Clinical Research launched in December 2017, it had just two sites. Owned sites (SMOs) were the prevalent model at the time, and site networks were a collection of … Read more

Quality. Continuity. Velocity.